CommonSpirit Grand Rounds/Clinical Update: Improving CKD Diagnosis and Management



Published
Topics Covered:

Review the story behind this improvement initiative, focused on identifying the latest guidelines on diagnosis of CKD, the roadmap of improvement, stakeholders involved, and the challenges overcome by teamwork and collaboration across various teams.

Acknowledge the needs of the community and the inequity addressed by this initiative.

Share the community outreach efforts to ensure populations at risk of CKD are aware of and engaged in improving the early diagnosis of CKD.
Recognize the importance of curbing the progression of CKD through the medications such as SGLT2 inhibitors.

Our goal is to recognize the milestone of the 96% of CommonSpirit laboratories that have transitioned, with an eye toward the future of chronic kidney disease diagnosis and management.

Guest Speakers:
Khalid Bashir, MD, FACP, FASN, Associate Professor Department of Medicine, Chief Renal Division, Creighton University School of Medicine; Associate Director, CHI Nephrology, Omaha, Nebraska

Victor Waters, MD, JD, FCLM, Chief Medical Officer, Dignity Health Arizona Market

E. Gaye Woods, MBa, System Vice President, CommonSpirit Health, Equity and Inclusion

Nathan Ziegler, PhD, System Vice President, Diversity, Leadership and Performance Excellence; Office of Diversity, Inclusion, Equity, and Belonging

Ankita Sagar, MD, MPH, FACP, System Vice President, Clinical Standards and Variation Reduction, Physician Enterprise
Category
Management
Be the first to comment